Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK's Karen Vousden to join BMS board

She will also serve on the pharma firm's Science and Technology Committee

Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January.

Vousden is currently chief scientist at Cancer Research UK, as well as serving as group leader at the Francis Crick Institute in London, will also sit the pharma firm's Science and Technology Committee.

She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National Cancer Institute.

Giovanni Caforio, BMS’ chairman and chief executive officer, said: "Karen is a world class cancer researcher and a highly accomplished leader in her field.

“Her understanding of cancer biology and immunology research will bring valuable insights to advancing our strategy and strong pipeline in oncology along with our broader pipeline of transformational medicines.”

18th September 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...

Infographics